Appropriate Analysis of Duration of Response Data in Cancer Trials-Reply
JAMA Oncol
.
2020 Dec 1;6(12):1978-1979.
doi: 10.1001/jamaoncol.2020.4664.
Authors
Michael Weller
1
,
Kay Tatsuoka
2
,
David A Reardon
3
Affiliations
1
Department of Neurology and Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland.
2
Bristol Myers Squibb, Princeton, New Jersey.
3
Dana-Farber/Harvard Cancer Center, Boston, Massachusetts.
PMID:
33030510
DOI:
10.1001/jamaoncol.2020.4664
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Neoplasms* / drug therapy